Rapid Response to Pembrolizumab in a Chemo-Refractory Testicular Germ Cell Cancer with Microsatellite Instability-High.
Onco Targets Ther
; 14: 4853-4858, 2021.
Article
in En
| MEDLINE
| ID: mdl-34584425
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Onco Targets Ther
Year:
2021
Document type:
Article
Affiliation country:
Japan
Country of publication:
New Zealand